Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Greer, Raquel C ^a   Powe, Neil R ^c   Jaar, Bernard G ^a,b,d,e   Troll, Misty U ^a,d   Boulware, L Ebony ^a,b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NEPHROLOGY CENTER OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

AFRICAN AMERICAN; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; EUROPEAN AMERICAN; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MEDICAL DECISION MAKING; PATIENT REFERRAL; PHYSICIAN; PRIMARY MEDICAL CARE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; GENERAL PRACTITIONER; STATISTICS; TIME; UNITED STATES; UTILIZATION REVIEW;

CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, PRIMARY CARE; REFERRAL AND CONSULTATION; TIME FACTORS; UNITED STATES;

EID: 78651363035     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-1     Document Type: Article

References (46)

1. Prevalence of chronic kidney disease in the United States. J Coresh E Selvin LA Stevens J Manzi JW Kusek P Eggers F Van Lente (Pubitemid 350074801)
2. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. AS Go GM Chertow D Fan CE McCulloch CY Hsu, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656
3. Outcomes in patients with chronic kidney disease referred late to nephrologists: A meta-analysis. MR Chan AT Dall KE Fletcher N Lu H Trivedi, Am J Med 2007 120 1063 1070 10.1016/j.amjmed.2007.04.024 18060927
4. The timing of specialist evaluation in chronic kidney disease and mortality. KS Kinchen J Sadler N Fink R Brookmeyer MJ Klag AS Levey NR Powe, Ann Intern Med 2002 137 479 486 12230348 (Pubitemid 35024618)
5. Section I. measurement of renal function, when to refer and when to start dialysis. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association, Nephrol Dial Transplant 2002 17 Suppl 7 7 15
6. Elevated levels of serum creatinine: Recommendations for management and referral. DC Mendelssohn BJ Barrett LM Brownscombe J Ethier DE Greenberg SD Kanani A Levin EB Toffelmire, CMAJ 1999 161 413 417 10478168 (Pubitemid 29412564)
7. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2002 39 2 Suppl 1 1 266 11904577
8. Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Prevention of progression of kidney disease: Early referral of patients with pre-end-stage kidney disease. MC Thomas, Nephrology (Carlton) 2007 12 Suppl 1 41 3 10.1111/j.1440-1797.2006.00716.x 17316278
9. Identification and referral of patients with progressive CKD: A national study. LE Boulware MU Troll BG Jaar DI Myers NR Powe, Am J Kidney Dis 2006 48 192 204 10.1053/j.ajkd.2006.04.073 16860184 (Pubitemid 44069609)
10. Recognition and management of chronic kidney disease in an elderly ambulatory population. MB Rothberg ED Kehoe AL Courtemanche T Kenosi PS Pekow MJ Brennan JG Mulhern GL Braden, J Gen Intern Med 2008 23 1125 1130 10.1007/s11606-008-0607-z 18443883
11. Perception of indications for nephrology referral among internal medicine residents: A national online survey. V Agrawal AK Ghosh MA Barnes PA McCullough, Clin J Am Soc Nephrol 2009 4 323 328 10.2215/CJN.03510708 19218472
12. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: A national online survey. V Agrawal AK Ghosh MA Barnes PA McCullough, Am J Kidney Dis 2008 52 1061 1069 10.1053/j.ajkd.2008.06. 022 18976845
13. Physician characteristics and knowledge of CKD management. RK Israni JA Shea MM Joffe HI Feldman, Am J Kidney Dis 2009 54 238 247 10.1053/j.ajkd.2009. 01.258 19359079
14. Chronic kidney disease care delivered by US family medicine and internal medicine trainees: Results from an online survey. O Lenz A Fornoni, BMC Med 2006 4 30 10.1186/1741-7015-4-30 17164005
15. Who is tested for diabetic kidney disease and who initiates treatment? The translating research into action for diabetes (TRIAD) study. SL Johnson EF Tierney KU Onyemere CW Tseng MM Safford AJ Karter A Ferrara OK Duru AF Brown KM Narayan TJ Thompson WH Herman, Diabetes Care 2006 29 1733 1738 10.2337/dc06-0260 16873772 (Pubitemid 44156622)
16. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: An Upstate New York practice-based research network (UNYNET) study. CH Fox A Brooks LE Zayas W McClellan B Murray, J Am Board Fam Med 2006 19 54 61 10.3122/jabfm.19.1.54 16492006 (Pubitemid 44046994)
17. Reporting of estimated glomerular filtration rate: Effect on physician recognition of chronic kidney disease and prescribing practices for elderly hospitalized patients. JM Quartarolo M Thoelke SJ Schafers, J Hosp Med 2007 2 74 78 10.1002/jhm.172 17427247 (Pubitemid 46730489)
18. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. A Akbari PJ Swedko HD Clark W Hogg J Lemelin P Magner L Moore D Ooi, Arch Intern Med 2004 164 1788 1792 10.1001/archinte.164.16.1788 15364673 (Pubitemid 39215649)
19. Reporting of estimated GFR in the primary care clinic. C Wyatt V Konduri J Eng R Rohatgi, Am J Kidney Dis 2007 49 634 641 10.1053/j.ajkd.2007.02.258 17472845 (Pubitemid 46654491)
20. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. modification of diet in renal disease study group. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth, Ann Intern Med 1999 130 461 470 10075613 (Pubitemid 29135798)
21. A new equation to estimate glomerular filtration rate. AS Levey LA Stevens CH Schmid YL Zhang AF Castro HI Feldman JW Kusek P Eggers F Van Lente T Greene J Coresh CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), Ann Intern Med 2009 150 604 612 19414839
22. Prevalence of estimated GFR reporting among US clinical laboratories. NA Accetta EH Gladstone C DiSogra EC Wright M Briggs AS Narva, Am J Kidney Dis 2008 52 778 787 10.1053/j.ajkd.2008.05.023 18676076
23. Estimating glomerular filtration rate. WG Miller, Clin Chem Lab Med 2009 47 1017 19 10.1515/CCLM.2009.264 19728841
24. Current status of reporting eGFR. http://www.cap.org/apps/docs/ committees/chemistry/current-status-reporting-egfr-09.pdf
25. Maintain and renew your certification: Overview/Guide. American Board of Internal Medicine, http://www.abim.org/moc/
26. Maintenance of certification. American Board of Family Physicians, https://www.theabfm.org/moc/index.aspx
27. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. J Zhang KF Yu, JAMA 1998 280 1690 1691 10.1001/jama.280.19.1690 9832001 (Pubitemid 28532993)
28. The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting. N Richards K Harris M Whitfield D O'Donoghue R Lewis M Mansell S Thomas J Townend M Eames D Marcelli, Nephrol Dial Transplant 2008 23 556 561 10.1093/ndt/gfm839 18065790 (Pubitemid 351767654)
29. Renal quality outcomes framework and eGFR: Impact on secondary care. LA Phillips KL Donovan AO Phillips, QJM 2009 102 415 423 10.1093/qjmed/hcp030 19349287
30. The impact of automated eGFR reporting and education on nephrology service referrals. E Noble DW Johnson N Gray P Hollett CM Hawley SB Campbell DW Mudge NM Isbel, Nephrol Dial Transplant 2008 23 3845 3850 10.1093/ndt/gfn385 18632591
31. The early impact of the United Kingdom chronic kidney disease (CKD) guidelines on the number of new attendances at renal clinics. H Aghaie-Jaladerany D Cowell CC Geddes, Scott Med J 2007 52 28 31 18092634
32. Referral patterns to renal services: What has changed in the past 4 years? H Hobbs P Stevens B Klebe J Irving R Cooley D O'Donoghue S Green C Farmer, Nephrol Dial Transplant 2009 24 3411 3419 10.1093/ndt/gfp289 19535434
33. When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. AK Jain I McLeod C Huo MS Cuerden A Akbari M Tonelli C van Walraven RR Quinn B Hemmelgarn MJ Oliver P Li AX Garg, Kidney Int 2009 76 318 323 10.1038/ki.2009.158 19436331
34. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. BR Hemmelgarn J Zhang BJ Manns MT James RR Quinn P Ravani SW Klarenbach BF Culleton R Krause L Thorlacius AK Jain M Tonelli Alberta Kidney Disease Network, JAMA 2010 303 1151 1158 10.1001/jama.2010.303 20332400
35. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. P Gaede P Vedel N Larsen GV Jensen HH Parving O Pedersen, N Engl J Med 2003 348 383 393 10.1056/NEJMoa021778 12556541 (Pubitemid 36159355)
36. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno Type 2 Randomised Study. P Gaede P Vedel HH Parving O Pedersen, Lancet 1999 353 617 622 10.1016/S0140-6736(98) 07368-1 10030326 (Pubitemid 29087981)
37. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. S Yusuf P Sleight J Pogue J Bosch R Davies G Dagenais, N Engl J Med 2000 342 145 153 10.1056/NEJM200001203420301 10639539
38. Timing of nephrologist referral and arteriovenous access use: The CHOICE study. BC Astor JA Eustace NR Powe MJ Klag JH Sadler NE Fink J Coresh, Am J Kidney Dis 2001 38 494 501 10.1053/ajkd.2001.26833 11532680 (Pubitemid 32803059)
39. Late referral to a nephrologist reduces access to renal transplantation. A Cass J Cunningham P Snelling JZ Ayanian, Am J Kidney Dis 2003 42 1043 1049 10.1016/j.ajkd.2003.07.006 14582048 (Pubitemid 37322921)
40. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
41. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr EJ Roccella, Hypertension 2003 42 1206 1252 10.1161/01.HYP.0000107251.49515.c2 14656957 (Pubitemid 37553153)
42. Timing of onset of CKD-related metabolic complications. O Moranne M Froissart J Rossert C Gauci JJ Boffa JP Haymann MB M'rad C Jacquot P Houillier B Stengel B Fouqueray NephroTest Study Group, J Am Soc Nephrol 2009 20 164 171 10.1681/ASN.2008020159 19005010
43. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. M Ravid R Lang R Rachmani M Lishner, Arch Intern Med 1996 156 286 289 10.1001/archinte.156.3.286 8572838 (Pubitemid 26058479)
44. 2008 physician specialty data: Center for Workforce Studies. https://www.aamc.org/download/47352/data/specialtydata.pdf
45. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Kidney Disease Outcomes Quality Initiative (K/DOQI), Am J Kidney Dis 2004 43 5 Suppl 1 1 290 15114537
46. Serum creatinine as an index of renal function: New insights into old concepts. RD Perrone NE Madias AS Levey, Clin Chem 1992 38 1933 1953 1394976